Boehringer Ingelheim’s Jascayd Gains FDA Approval, Offering First New Treatment in 10+ Years for Idiopathic Pulmonary Fibrosis

By Team VOH

The U.S. Food and Drug Administration (FDA) has approved Jascayd (nerandomilast) tablets

Read more